Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis

Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis

ABSTRACT Aims/Introduction We previously reported that sodium–glucose cotransporter 2 inhibitor (SGLT2i) treatment was associated with an improvement of the albumin‐to‐creatinine ratio in Japanese patients with type 2 diabetes mellitus and chronic kidney disease. The present study clarified how conc...

Full description

Bibliographic Details
Main Authors: Masao Toyoda, Nobumichi Saito, Moritsugu Kimura, Nobuo Hatori, Kouichi Tamura, Masaaki Miyakawa, Kazuyoshi Sato, Akira Kanamori, Kazuo Kobayashi
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Journal of Diabetes Investigation
Subjects:
Insulin treatment
Renal composite outcome
Sodium–glucose cotransporter 2 inhibitors
Online Access:https://doi.org/10.1111/jdi.13825

Internet

https://doi.org/10.1111/jdi.13825

Similar Items